Aberdeen Group’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-38,071
| Closed | -$3.68M | – | 968 |
|
|
2024
Q1 | $3.68M | Hold |
38,071
| – | – | 0.01% | 709 |
|
|
2023
Q4 | $3.84M | Buy |
+38,071
| New | +$3.84M | 0.01% | 713 |
|
|
2019
Q4 | – | Sell |
-5,400
| Closed | -$469K | – | 944 |
|
|
2019
Q3 | $469K | Hold |
5,400
| – | – | ﹤0.01% | 862 |
|
|
2019
Q2 | $493K | Sell |
5,400
-626
| -10% | -$57.2K | ﹤0.01% | 876 |
|
|
2019
Q1 | $519K | Sell |
6,026
-200,992
| -97% | -$17.3M | ﹤0.01% | 857 |
|
|
2018
Q4 | $15.6M | Sell |
207,018
-1,674
| -0.8% | -$126K | 0.04% | 381 |
|
|
2018
Q3 | $16.1M | Sell |
208,692
-48,658
| -19% | -$3.76M | 0.03% | 417 |
|
|
2018
Q2 | $17.4M | Buy |
257,350
+249,092
| +3,016% | +$16.9M | 0.03% | 394 |
|
|
2018
Q1 | $598K | Hold |
8,258
| – | – | ﹤0.01% | 760 |
|
|
2017
Q4 | $621K | Buy |
8,258
+446
| +6% | +$33.5K | ﹤0.01% | 759 |
|
|
2017
Q3 | $601K | Buy |
+7,812
| New | +$601K | ﹤0.01% | 746 |
|